SMN1 and TARP syndrome: The usefulness of our findings, with regards to SMA, would depend on the identification of an RBM10 antagonist that could specifically target motor neurons important to SMA, since downregulation of RBM10 (particularly during embryonic development) is the causative agent for TARP syndrome [9, 10].